Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass

NCT04003467 is registered in ClinicalTrials.gov with Entera Bio Ltd. as lead sponsor.

NCT NCT04003467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04003467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
Lead sponsor
Entera Bio Ltd.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2019
Completion date
May 11, 2021
Enrollment
161 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis